Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
2000 2
2002 1
2006 1
2007 1
2008 2
2009 1
2010 1
2013 2
2014 2
2015 2
2017 5
2018 2
2020 4
2021 2
2022 3
2023 6
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species.
Czajka KM, Venkataraman K, Brabant-Kirwan D, Santi SA, Verschoor C, Appanna VD, Singh R, Saunders DP, Tharmalingam S. Czajka KM, et al. Cells. 2023 Nov 19;12(22):2655. doi: 10.3390/cells12222655. Cells. 2023. PMID: 37998390 Free PMC article. Review.
Therefore, an overview of the known gene mutations is presented for the following antifungals: azoles (fluconazole, voriconazole, posaconazole and itraconazole), echinocandins (caspofungin, anidulafungin and micafungin), polyenes (amphotericin B and nystatin) and 5-fluoroc …
Therefore, an overview of the known gene mutations is presented for the following antifungals: azoles (fluconazole, voriconazole, posaconazo …
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
Muñoz FM, Sher LD, Sabharwal C, Gurtman A, Xu X, Kitchin N, Lockhart S, Riesenberg R, Sexter JM, Czajka H, Paulsen GC, Maldonado Y, Walter EB, Talaat KR, Englund JA, Sarwar UN, Hansen C, Iwamoto M, Webber C, Cunliffe L, Ukkonen B, Martínez SN, Pahud BA, Munjal I, Domachowske JB, Swanson KA, Ma H, Koury K, Mather S, Lu C, Zou J, Xie X, Shi PY, Cooper D, Türeci Ö, Şahin U, Jansen KU, Gruber WC; C4591007 Clinical Trial Group. Muñoz FM, et al. Among authors: czajka h. N Engl J Med. 2023 Feb 16;388(7):621-634. doi: 10.1056/NEJMoa2211031. N Engl J Med. 2023. PMID: 36791162 Free PMC article. Clinical Trial.
On the basis of preliminary immunogenicity results, a third 3-mug dose (8 weeks after dose 2) was administered starting in January 2022, which coincided with the emergence of the B.1.1.529 (omicron) variant. Immune responses at 1 month after doses 2 and 3 in children 6 mon …
On the basis of preliminary immunogenicity results, a third 3-mug dose (8 weeks after dose 2) was administered starting in January 2022, whi …
Breast Cancer Surgery.
Czajka ML, Pfeifer C. Czajka ML, et al. 2023 Feb 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Feb 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31971717 Free Books & Documents.
The National Surgical Adjuvant Breast and Bowel Project (NSABP) B-04 was instrumental in this transition. The study examined radical mastectomy to total mastectomy with or without radiation therapy. ...To further direct treatment away from radical approaches, the NSABP …
The National Surgical Adjuvant Breast and Bowel Project (NSABP) B-04 was instrumental in this transition. The study examined radical …
Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial.
Peterson J, Drazan D, Czajka H, Maguire J, Pregaldien JL, Seppa I, Maansson R, O'Neill R, Balmer P, Jodar L, Jansen KU, Anderson AS, Perez JL, Beeslaar J. Peterson J, et al. Among authors: czajka h. Lancet Infect Dis. 2023 Dec;23(12):1370-1382. doi: 10.1016/S1473-3099(23)00191-3. Epub 2023 Aug 11. Lancet Infect Dis. 2023. PMID: 37579773 Clinical Trial.
BACKGROUND: Meningococcal serogroups A, B, C, W, and Y cause nearly all meningococcal disease, and comprehensive protection requires vaccination against all five serogroups. We aimed to assess the immunogenicity and safety of a pentavalent MenABCWY vaccine comprising two l …
BACKGROUND: Meningococcal serogroups A, B, C, W, and Y cause nearly all meningococcal disease, and comprehensive protection requires …
Orphan high field superconductivity in non-superconducting uranium ditelluride.
Frank CE, Lewin SK, Saucedo Salas G, Czajka P, Hayes IM, Yoon H, Metz T, Paglione J, Singleton J, Butch NP. Frank CE, et al. Among authors: czajka p. Nat Commun. 2024 Apr 20;15(1):3378. doi: 10.1038/s41467-024-47090-1. Nat Commun. 2024. PMID: 38643147 Free PMC article.
This high-field orphan superconductivity exists at angles offset between 29(o) and 42(o) from the crystallographic b to c axes with applied fields between 37 T and 52 T. The stability of field-induced orphan superconductivity presented in this work defies both empirical pr …
This high-field orphan superconductivity exists at angles offset between 29(o) and 42(o) from the crystallographic b to c axes with a …
Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.
Abu-Shawareb H, Acree R, Adams P, Adams J, Addis B, Aden R, Adrian P, Afeyan BB, Aggleton M, Aghaian L, Aguirre A, Aikens D, Akre J, Albert F, Albrecht M, Albright BJ, Albritton J, Alcala J, Alday C, Alessi DA, Alexander N, Alfonso J, Alfonso N, Alger E, Ali SJ, Ali ZA, Alley WE, Amala P, Amendt PA, Amick P, Ammula S, Amorin C, Ampleford DJ, Anderson RW, Anklam T, Antipa N, Appelbe B, Aracne-Ruddle C, Araya E, Arend M, Arnold P, Arnold T, Asay J, Atherton LJ, Atkinson D, Atkinson R, Auerbach JM, Austin B, Auyang L, Awwal AS, Ayers J, Ayers S, Ayers T, Azevedo S, Bachmann B, Back CA, Bae J, Bailey DS, Bailey J, Baisden T, Baker KL, Baldis H, Barber D, Barberis M, Barker D, Barnes A, Barnes CW, Barrios MA, Barty C, Bass I, Batha SH, Baxamusa SH, Bazan G, Beagle JK, Beale R, Beck BR, Beck JB, Bedzyk M, Beeler RG, Beeler RG, Behrendt W, Belk L, Bell P, Belyaev M, Benage JF, Bennett G, Benedetti LR, Benedict LX, Berger R, Bernat T, Bernstein LA, Berry B, Bertolini L, Besenbruch G, Betcher J, Bettenhausen R, Betti R, Bezzerides B, Bhandarkar SD, Bickel R, Biener J, Biesiada T, Bigelow K, Bigelow-Granillo J, Bigman V, Bionta RM, Birge NW, Bitter M, Black AC, Bleile R, Bleuel DL, Bliss E,… See abstract for full author list ➔ Abu-Shawareb H, et al. Among authors: czajka ce. Phys Rev Lett. 2022 Aug 12;129(7):075001. doi: 10.1103/PhysRevLett.129.075001. Phys Rev Lett. 2022. PMID: 36018710 Free article.
A Biparatopic Intrabody Renders Vero Cells Impervious to Ricin Intoxication.
Czajka TF, Vance DJ, Song R, Mantis NJ. Czajka TF, et al. bioRxiv [Preprint]. 2024 Jul 3:2024.07.02.601761. doi: 10.1101/2024.07.02.601761. bioRxiv. 2024. Update in: Biochemistry. 2024 Oct 1;63(19):2391-2396. doi: 10.1021/acs.biochem.4c00385 PMID: 39005371 Free PMC article. Updated. Preprint.
In this report, we describe a heterodimeric intrabody that renders Vero cells virtually impervious to ricin toxin (RT), a potent Category B ribosome-inactivating protein (RIP). The intrabody consists of two structurally defined V(H)Hs that target distinct epitopes on RT's …
In this report, we describe a heterodimeric intrabody that renders Vero cells virtually impervious to ricin toxin (RT), a potent Category …
A Biparatopic Intrabody Renders Vero Cells Impervious to Ricin Intoxication.
Czajka TF, Vance DJ, Song R, Mantis NJ. Czajka TF, et al. Biochemistry. 2024 Oct 1;63(19):2391-2396. doi: 10.1021/acs.biochem.4c00385. Epub 2024 Sep 19. Biochemistry. 2024. PMID: 39297955
In this report, we describe a heterodimeric intrabody that renders Vero cells virtually impervious to ricin toxin (RT), a potent Category B ribosome-inactivating protein. The intrabody consists of two structurally defined V(H)Hs that target distinct epitopes on RT's enzyma …
In this report, we describe a heterodimeric intrabody that renders Vero cells virtually impervious to ricin toxin (RT), a potent Category …
38 results